These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564 [TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694 [TBL] [Abstract][Full Text] [Related]
10. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844 [TBL] [Abstract][Full Text] [Related]
11. Switching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniques. Perahia DG; Quail D; Desaiah D; Corruble E; Fava M J Clin Psychiatry; 2008 Jan; 69(1):95-105. PubMed ID: 18312043 [TBL] [Abstract][Full Text] [Related]
12. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram. Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206 [TBL] [Abstract][Full Text] [Related]
13. Duloxetine: a review of its use in the treatment of generalized anxiety disorder. Carter NJ; McCormack PL CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470 [TBL] [Abstract][Full Text] [Related]
14. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411 [TBL] [Abstract][Full Text] [Related]
15. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder. Brecht S; Kajdasz D; Ball S; Thase ME Int Clin Psychopharmacol; 2008 Nov; 23(6):317-24. PubMed ID: 18854719 [TBL] [Abstract][Full Text] [Related]
17. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888 [TBL] [Abstract][Full Text] [Related]
18. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722 [TBL] [Abstract][Full Text] [Related]
20. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Abarca JE; Herrera-Guzmán D; Montelongo-Pedraza P; Padrós Blázquez F; Peró-Cebollero M; Guàrdia-Olmos J J Affect Disord; 2010 Jun; 123(1-3):341-50. PubMed ID: 19896719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]